Tag Archives: QURE

Analysts Have Conflicting Sentiments on These Healthcare Companies: uniQure (NASDAQ: QURE) and Rhythm Pharmaceuticals (NASDAQ: RYTM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on uniQure (QURE – Research Report) and Rhythm Pharmaceuticals (RYTM – Research Report). uniQure (QURE) uniQure received a Hold rating and a $61.00 price target from

Mizuho Securities Keeps Their Buy Rating on uniQure (QURE)

In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on uniQure (QURE – Research Report), with a price target of $90.00. The company’s shares closed last Wednesday at $63.27. According to TipRanks.com, Yang ‘s ranking

uniQure (QURE) Receives a Rating Update from a Top Analyst

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE – Research Report) today and set a price target of $105.00. The company’s shares closed last Monday at $56.50. According to TipRanks.com, Amusa is a top 100 analyst

Friday’s Highlights at Noon: Monitronics International (SCTY), Vertex Pharmaceuticals (VRTX), uniQure (QURE), Cytokinetics (CYTK), Novavax (NVAX)

So far Friday, January 31, NASDAQ is down -4.7% and the S&P is down -3.75%. Here are this morning’s most active stocks: Monitronics International (SCTY – Research Report), Vertex Pharmaceuticals (VRTX – Research Report), uniQure (QURE – Research Report), Cytokinetics

uniQure (QURE) Received its Third Buy in a Row

After Cantor Fitzgerald and Chardan Capital gave uniQure (NASDAQ: QURE) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Debjit Chattopadhyay reiterated a Buy rating on uniQure today and set a price target

Thursday’s Midday Movers: uniQure (QURE), Alcoa (AA), Goodrich Petroleum (GDP), Second Sight Medical Products (EYES)

So far Thursday, January 16, NASDAQ is up 0.8% and the S&P is up 0.11%. Here are this morning’s most active stocks: uniQure (QURE – Research Report), Alcoa (AA – Research Report), Goodrich Petroleum (GDP – Research Report) and Second